The most striking feature of liver failure was the elevation of CCL23, FGF2, and KRLD1 and depression of KIR3DL1 at admission, while Gal-1 and DCN were decreased later during the history of COVID-19 (Figure 7C and Supplemental Material 2). The gene discussed is GAL; the disease is Hepatic failure.